Client News

[PR Newswire] - VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 4, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ...
Posted: September 4, 2015, 11:30 am
Posted: September 3, 2015, 4:08 pm
[at noodls] - NEW YORK , Sept. 3, 2015 /PRNewswire / -- Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) ('Immune' or the 'Company') announced today that its first R&D day will take place on September 8, 2015 at 2pm at the ...
Posted: September 3, 2015, 1:45 pm
[PR Newswire] - NEW YORK, Sept. 3, 2015 /PRNewswire/ -- Immune Pharmaceuticals, Inc. (IMNP) ("Immune" or the "Company") announced today that its first R&D day will take place on September 8, 2015 at 2pm at the Alexandria Center for Life Science in New York City. Robert Goldberg, PhD will present on the importance of Precision Medicine to create value for patients and for the healthcare system. Neil Korman, MD- Chairman of Dermatology, Case Western School of Medicine, Cleveland, OH will present the role of eotaxin-1 in Dermatology and the clinical potential of bertilimumab.
Posted: September 3, 2015, 12:00 pm
[at noodls] - DUBLIN, Ohio--(BUSINESS WIRE)--Sep. 3, 2015-- Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB) is announcing the receipt of an initial notice of award for a Fast Track Small Business Innovation Research ...
Posted: September 3, 2015, 11:45 am
[Business Wire] - Navidea Biopharmaceuticals, Inc. is announcing the receipt of an initial notice of award for a Fast Track Small Business Innovation Research grant providing for up to $1.8 million from the National Cancer Institute , National Institutes of Health , to fund preclinical studies examining the safety of intravenous injection of Tc99m tilmanocept, a Manocept™ platform product, followed by a clinical study ...
Posted: September 3, 2015, 11:30 am
[at noodls] - SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/03/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company ...
Posted: September 3, 2015, 11:25 am
[at noodls] - Research Triangle Park, NC, September 3, 2015 - Fennec Pharmaceuticals, Inc. (TSX: FRX, OTCQB: FENCF), today announced that Rosty Raykov, CEO of Fennec, will present at the Rodman & Renshaw 17th Annual ...
Posted: September 3, 2015, 11:15 am
[Marketwired] - Threshold Pharmaceuticals, Inc. today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at the Rodman & Renshaw Annual Global Investment Conference ...
Posted: September 3, 2015, 11:00 am
[at noodls] - DUBLIN, Ohio--(BUSINESS WIRE)--Sep. 2, 2015-- Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), announces that Rick Gonzalez, President and Chief Executive Officer, will present a corporate overview on ...
Posted: September 2, 2015, 8:04 pm
[Business Wire] - Navidea Biopharmaceuticals, Inc. , announces that Rick Gonzalez, President and Chief Executive Officer, will present a corporate overview on Thursday, September 10, 2015 at 9:30 AM EDT at the 22nd Annual NewsMakers in the Biotech Industry, taking place at the Millennium Broadway Hotel & Conference Center, New York City, NY.
Posted: September 2, 2015, 7:27 pm
[at noodls] - Aurinia Pharmaceuticals to Present at the 2015 Rodman & Renshaw 17th Annual Global Investment Conference Victoria, British Columbia - September 2, 2015 - Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX:AUP) ...
Posted: September 2, 2015, 1:44 pm
Posted: September 2, 2015, 1:30 pm